Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

139 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Role of central and peripheral chemoreceptors in vasopressin secretion control.
Iovino M, Guastamacchia E, Giagulli VA, Fiore G, Licchelli B, Iovino E, Triggiani V. Iovino M, et al. Among authors: iovino e. Endocr Metab Immune Disord Drug Targets. 2013 Sep;13(3):250-5. doi: 10.2174/18715303113136660042. Endocr Metab Immune Disord Drug Targets. 2013. PMID: 24032393 Review.
Amiodarone-induced SIADH: two cases report.
Iovino M, Iovine N, Petrosino A, Licchelli B, Giagulli VA, Iacoviello M, Guastamacchia E, Triggiani V. Iovino M, et al. Endocr Metab Immune Disord Drug Targets. 2014;14(2):123-5. doi: 10.2174/1871530314666140407111410. Endocr Metab Immune Disord Drug Targets. 2014. PMID: 24712668
Sevelamer carbonate markedly reduces levothyroxine absorption.
Iovino M, Iovine N, Petrosino A, Giagulli VA, Licchelli B, Guastamacchia E, Triggiani V. Iovino M, et al. Endocr Metab Immune Disord Drug Targets. 2014;14(3):206-9. doi: 10.2174/1871530314666140902151804. Endocr Metab Immune Disord Drug Targets. 2014. PMID: 25183496
Hypopituitarism in Neurocritical Patients: A Case Report.
Iovino M, Iovine N, Mondillo F, Guastamacchia E, Licchelli B, Giagulli VA, Triggiani V. Iovino M, et al. Endocr Metab Immune Disord Drug Targets. 2016;16(1):28-31. doi: 10.2174/1871530315666150930121912. Endocr Metab Immune Disord Drug Targets. 2016. PMID: 26420547
Vasopressin in Heart Failure.
Iovino M, Iacoviello M, De Pergola G, Licchelli B, Iovino E, Guastamacchia E, Giagulli VA, Triggiani V. Iovino M, et al. Among authors: iovino e. Endocr Metab Immune Disord Drug Targets. 2018;18(5):458-465. doi: 10.2174/1871530318666180212095235. Endocr Metab Immune Disord Drug Targets. 2018. PMID: 29437026 Review.
Vigilance States: Central Neural Pathways, Neurotransmitters and Neurohormones.
Iovino M, Messana T, De Pergola G, Iovino E, Guastamacchia E, Giagulli VA, Triggiani V. Iovino M, et al. Among authors: iovino e. Endocr Metab Immune Disord Drug Targets. 2019;19(1):26-37. doi: 10.2174/1871530318666180816115720. Endocr Metab Immune Disord Drug Targets. 2019. PMID: 30113008 Review.
Neuroendocrine Mechanisms Involved in Male Sexual and Emotional Behavior.
Iovino M, Messana T, Iovino E, De Pergola G, Guastamacchia E, Giagulli VA, Triggiani V. Iovino M, et al. Among authors: iovino e. Endocr Metab Immune Disord Drug Targets. 2019;19(4):472-480. doi: 10.2174/1871530319666190131155310. Endocr Metab Immune Disord Drug Targets. 2019. PMID: 30706797 Free PMC article. Review.
139 results